Label: VIAL KIT3.98- saussurea involucrata, bee venom, sodium hyaluronate liquid
- NDC Code(s): 80851-301-01
- Packager: Oxytical
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Updated November 11, 2020
If you are a consumer or patient please visit this version.
Saussurea Involucrata help to improve the appearance of firmness and elasticity on the skin's surface.
Bee Venom combined with high-grade Peptides helps to visibly reduce the appearance of fine lines and wrinkles on the skin's surface.
Sodium Hyaluronate known for its restorative and anti-aging abilities, revitalizes and moisturizes skin’s outer surface layers to improve appearance of fine lines and wrinkles.
The skin's surface appears firmer and smoother with a more youthful look. Remodels the facial contours and reduces the thickness of subcutaneous fatty tissue helping to reduce the "double chin effect" providing you with a youthful complexion. Reinforces skin elasticity to provide plump and radiant complexion.
After cleansing, use toner to clean up the skin.
It must be used only after cleansing is complete, and especially pay attention to the cleanliness of your hands.
If you use it after exfoliation, you can get more satisfactory results, and it is more effective if you give a simple massage before use.
1. Prepare Core peptide(1st), Stable Chitin(2nd) and a syringe.
2. Core Peptide(1st) only opens the plastic cap.
3. A syringe inlet is injected into the center of the hole at the top of the Core Peptide(1st) to suction. (Total 3ml based on syringe).
After the syringe is removed, the inlet is automatically sealed to prevent outside air from entering.
4. Open the Stable Chitin(2nd) after referring to the precautions and inject the Core Peptide(1st).
Due to the nature of the Stable Chitin component, it is not soluble in ampoule other than Core Peptide. (Not compatible)
5. Close the vial opening of the Stable Chitin(2nd) with an elastomer tube and shake to dissolve the Stable Chitin.
Check with eyes and if the Stable Chitin component does not appear in the form of a thread (slightly thick), apply it to the skin.
Although it can be used immediately after melting, it is recommended to use after 12 hours after mixing the product and closing it with an elastomer tube after mixing the product to increase the activity and maximize the efficacy due to the nature of the formulation.
After blending, only the elastomer tube is closed and stored at room temperature fresh out of direct sunlight.
(Up to 21 days)
- Stop use
- Keep out of reach of children
- Package Label
INGREDIENTS AND APPEARANCE
saussurea involucrata, bee venom, sodium hyaluronate liquid
Product Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:80851-301 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM 0.01 g in 100 mL SAUSSUREA INVOLUCRATA FLOWERING TOP (UNII: 65D06L9K7F) (SAUSSUREA INVOLUCRATA FLOWERING TOP - UNII:65D06L9K7F) SAUSSUREA INVOLUCRATA FLOWERING TOP 0.2 g in 100 mL APIS MELLIFERA VENOM (UNII: 76013O881M) (APIS MELLIFERA VENOM - UNII:76013O881M) APIS MELLIFERA VENOM 0.01 g in 100 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) PREZATIDE COPPER (UNII: 6BJQ43T1I9) SODIUM LACTATE (UNII: TU7HW0W0QT) PEG-60 HYDROGENATED CASTOR OIL (UNII: 02NG325BQG) CHLORPHENESIN (UNII: I670DAL4SZ) LACTIC ACID (UNII: 33X04XA5AT) GLYCERETH-26 (UNII: NNE56F2N14) FD&C YELLOW NO. 5 (UNII: I753WB2F1M) DIPEPTIDE DIAMINOBUTYROYL BENZYLAMIDE DIACETATE (UNII: 38H206R00R) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) PROPANEDIOL (UNII: 5965N8W85T) FRAGRANCE CLEAN ORC0600327 (UNII: 329LCV5BTF) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:80851-301-01 20 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product 11/11/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 11/11/2020 Labeler - Oxytical (695504108) Registrant - Oxytical (695504108)